Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Transfer of Microbiological Analytical Methods – V 2.0

Posted on By

Analytical Method Development: SOP for Transfer of Microbiological Analytical Methods – V 2.0

Standard Operating Procedure for Transfer of Microbiological Analytical Methods in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/302/2025
Supersedes SOP/AMD/302/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for transferring validated microbiological analytical methods from a sending laboratory (SU) to a receiving laboratory (RU), including aseptic technique verification, method equivalency assessment, and

documentation requirements.

2. Scope

This SOP applies to the transfer of microbiological analytical methods such as microbial enumeration, sterility testing, endotoxin testing, and antimicrobial efficacy testing between internal sites and contract laboratories.

3. Responsibilities

  • SU Microbiologist: Provides method details, validation reports, reference cultures, and training to the RU.
  • RU Analyst: Performs method execution under supervision and participates in comparative analysis.
  • QA Officer: Ensures method documentation, regulatory compliance, and approval of the transfer report.
See also  Analytical Method Development: SOP for Compatibility Testing of Actives with Diluent - V 2.0

4. Accountability

The Microbiology Section Head in AMD is accountable for ensuring successful execution, documentation, and regulatory compliance of all microbiological method transfer activities.

5. Procedure

5.1 Pre-Transfer Requirements

  1. Ensure that the method has been validated by the SU as per ICH Q2(R1).
  2. Review media qualification records and environmental monitoring capabilities at RU.
  3. Conduct analyst training and qualification at RU on aseptic handling and method specifics.
  4. Prepare Method Transfer Protocol (refer SOP/AMD/296/2025) specific to microbiological parameters.

5.2 Method Transfer Execution

  1. Use test organisms from certified sources (e.g., ATCC strains).
  2. Perform method in parallel at SU and RU using identical sample batches, media, and incubation conditions.
  3. Document all recovery rates, incubation logs, dilution records, and test timings.

5.3 Acceptance Criteria

  • For microbial limits and enumeration:
    • Difference in CFU count between RU and SU ≤ 0.5 log10
    • Recovery rate for specified organisms ≥ 70%
  • For endotoxin testing:
    • Geometric mean recovery within 50–200% of labeled spike
  • No contamination or false positives in sterility blanks
See also  Analytical Method Development: SOP for Determination of Enteric Coating Integrity - V 2.0

5.4 Documentation and Reporting

  1. Compile raw data, result tables, photographs (if applicable), and microbiological media logs.
  2. Complete the Method Transfer Summary Report (Annexure-3).
  3. Submit report to QA for review and approval.

5.5 Troubleshooting and Deviation Handling

  1. Record any method deviations in Deviation Log (Annexure-2).
  2. Conduct root cause analysis for deviations using microbiological investigation tools (e.g., growth promotion testing, environmental swabs).
  3. Repeat testing under corrected conditions with QA approval.

6. Abbreviations

  • RU: Receiving Unit
  • SU: Sending Unit
  • CFU: Colony Forming Units
  • GMP: Good Manufacturing Practice
  • ATP: Adenosine Triphosphate (used in rapid methods)

7. Documents

  1. Microbiological Method Transfer Protocol – Annexure-1
  2. Deviation Log – Annexure-2
  3. Method Transfer Summary Report – Annexure-3

8. References

  • USP <61>, <62>, <71>, <85>, <1116>
  • ICH Q2(R1): Validation of Analytical Procedures
  • WHO TRS 961 Annex 7: Analytical Method Transfer

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Rekha Pillai Pradeep Mehta Sunita Reddy
Designation Microbiologist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Microbiological Method Transfer Protocol

Includes: organism list, media types, incubation parameters, method summary, analyst qualifications, acceptance criteria.

Annexure-2: Deviation Log

Deviation ID Description Root Cause Corrective Action Status
DEV-302-01 Low recovery of S. aureus Expired TSA plate Replaced media and repeated test Closed

Annexure-3: Method Transfer Summary Report

Method: Bacterial Endotoxin Test
RU: Micro QC Lab – Mumbai
SU: AMD – Hyderabad
Result: Transfer Successful, all spike recoveries within 80–150% range. No deviations reported.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Expanded scope to include rapid methods and root cause protocols Annual Review Sunita Reddy
20/07/2022 1.0 Initial Release New SOP QA Head
See also  Analytical Method Development: Complexometric Titration Method Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: How to Use Change Control for SOP Revisions
Next Post: How to Address the Absence of Escalation Process in CAPA SOPs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version